United States Antimony (UAMY) Q1 2025 Earnings Call May 08, 2025 04:15 PM ET Company Participants Gary Evans - CEO & ChairmanRichard Isaak - Senior VP & CFOJoe Bardswich - EVP, Chief Mining Officer & DirectorJonathan Miller - VP of Investor Relations & Global Sales Manager Operator Welcome to the United States Antimony Corporation First Quarter twenty twenty five Financial and Operational Results Meeting. At this time, all participants are in a listen only mode. A question and answer session will follow the ...

Howard Hughes Holdings (HHH) Q1 2025 Earnings Call May 08, 2025 10:00 AM ET Speaker0 Thank you for standing by and welcome to the Howard Hughes Management's First Quarter twenty twenty five Earnings Conference Call. At this time, all participants are in listen only mode. After the speakers' presentation, there will be a question and answer session. As a reminder, today's program is being recorded. And now I'd like to introduce your host for today's program, Eric Holcomb, Senior Vice President of Investor Re ...

GRIFFON OVERVIEW Copyright © 2025 Griffon Corporation. All rights reserved. Q1 FY25 INVESTOR PRESENTATION FEBRUARY 2025 Compelling opportunity for shareholder value creation supported by operating performance, deleveraging and capital allocation priorities $2.6B $528M $3.5B 20% $1.3B 5,160 Revenue Adj. EBITDA Market Cap1 Adj. EBITDA Margin Net debt Employees B R E A K D O W N B Y O P E R A T I N G S E G M E N T CPP 39% Adjusted EBITDA (excl. unallocated) ($millions) Revenue U.S. 82% Int'l 18% $503 $85 CPP H ...

AMG: Strategic Partner to Industry-Leading Independent Investment Firms 30+ years of partnering with leading investment specialists 35+ independent Affiliates offering diverse suite of investment products Q1 2025 Investor Overview 3 ~$712B Assets Under Management Industry-Leading Independent Managers Attractive partnership model self-selects entrepreneurial, growing firms and enables access to specialist capabilities at scale High-Quality, Diverse Product Set Excellent breadth and quality of products manage ...

I give a hold rating for GFL Environmental Inc. ( GFL ) as I believe the current valuation already reflects its strong operational performance and near-term upside. While GFL is executing well, its stock has seen aI’m a fundamental, valuation-driven investor with a strong focus on identifying businesses that have the potential to scale over time and unlock massive terminal value. My investment approach centers around understanding the core economics of a business—its competitive moat, unit economics, reinve ...

Horace Mann Educators (HMN) Q1 2025 Earnings Call May 07, 2025 12:00 PM ET Company Participants Brendan Dawal - VP Financial Planning & Analysis, Investor RelationsMarita Zuraitis - President and Chief Executive OfficerRyan Greenier - Executive Vice President and CFOWilma Burdis - DirectorStephen McAnena - EVP & Chief Operating Officer Conference Call Participants John Barnidge - Managing Director & Senior Research Analyst Operator Good day, and welcome to the Horace Mann Educator First Quarter twenty twent ...

Horace Mann Educators (HMN) Q1 2025 Earnings Call May 07, 2025 12:00 PM ET Speaker0 Good day, and welcome to the Horace Mann Educator First Quarter twenty twenty five Investors Call. All participants will be in listen only mode. After today's presentation, there will be an opportunity to ask questions. Please note this event is being recorded. I would now like to turn the conference over to Brendan DeWall, Vice President, Investor Relations. Please go ahead. Speaker1 Thank you. Welcome to Horace Mann's disc ...

TransDigm Group (TDG) Q2 2025 Earnings Call May 06, 2025 11:00 AM ET Company Participants Jaimie Stemen - Director of Investor RelationsKevin Stein - President and CEOMichael Lisman - Co-Chief Operating OfficerSarah Wynne - Chief Financial OfficerRobert Stallard - PartnerScott Mikus - Director – Aerospace, Defense & Space ResearchKristine Liwag - Executive DirectorJoshua Korn - AVP - Equity ResearchSheila Kahyaoglu - Managing DirectorKen Herbert - Managing DirectorMyles Walton - Managing DirectorSeth Seifma ...

Financial Data and Key Metrics Changes - Total investment income for Q1 2025 was $2,000,000, a slight decline of $59,000 or 3% from the prior year period, primarily due to lower dividend income and an 8% reduction in interest income [18] - Net investment income increased by 45% year over year to $1,200,000 or $0.42 per share, compared to $840,000 or $0.33 per share in Q1 2024 [21] - Net asset value per share decreased to $21.99 from $25.31 at year-end 2024, reflecting the dilutive impact from the issuance of additional shares [22] Business Line Data and Key Metrics Changes - The portfolio stood at a fair value of approximately $62,000,000 across 19 businesses, a decline from year-end 2024, primarily due to loan repayments from three portfolio companies [10] - Debt investments now represent 72% of the portfolio, up from prior years, supporting greater earnings stability [11] - The annualized weighted average yield on debt investments was 12.2%, down from prior quarters due to one debt investment being on nonaccrual status [11] Market Data and Key Metrics Changes - The number of portfolio companies contributing to investment income decreased to 18 from 24 in the same period last year [18] - Exposure to professional services decreased from 48% to 45%, and manufacturing declined from 13% to 8%, while consumer products grew as a share of the portfolio [14] Company Strategy and Development Direction - The company aims to maintain a strong financial position and has repaid $600,000 of its revolver debt, ending the quarter with nearly $5,000,000 in cash and over $22,000,000 in available credit capacity [6] - The focus remains on disciplined execution, proactive portfolio oversight, and building sustainable shareholder value [7] - The investment strategy prioritizes structures where subordinated debt provides a yield-based return while capturing potential upside through equity participation [12] Management's Comments on Operating Environment and Future Outlook - Management acknowledged ongoing macroeconomic and political uncertainty affecting new investment opportunities but remains optimistic about capitalizing on conditions as they improve [6][27] - The company is committed to driving NAV growth and total returns through active portfolio oversight and sound financial management [28] Other Important Information - The company declared a regular quarterly cash dividend of $0.29 per share, payable on or about June 13, 2025 [23] - The Board of Directors renewed the share repurchase program, authorizing the repurchase of up to 1,500,000 shares [24] Q&A Session Summary - No specific questions or answers were documented in the provided content, thus this section is not applicable.

Company Overview - Qiagen NV is a Netherlands-based holding company that provides "Sample to Insight" solutions, transforming biological samples into molecular insights through integrated sample and assay technologies, bioinformatics, and automation systems [1] - The company specializes in isolating and preparing DNA, RNA, and proteins from various biological materials, and its assay technologies enable the analysis of these biomolecules [1] - Qiagen operates primarily in two end markets: Molecular Diagnostics and Life Sciences, generating approximately 90% of its sales from recurring consumables revenue [4] Investment Context - Fivespan Partners has established a position in Qiagen and is engaging with its management to explore potential improvements [3][7] - Qiagen has struggled to create shareholder value post-Covid, with 1-, 3-, and 5-year returns of 1%, -6%, and 1%, respectively, while trading at around 13 times EV/EBITDA compared to peers at approximately 15 times [5] - The company has a strong market position and brand reputation but has lost focus on its core business, leading to missed opportunities for growth [6] Strategic Opportunities - Management is encouraged to invest more in its core business, improve communication with the market, and optimize its balance sheet to enhance shareholder value [6] - Qiagen's operating margin is currently at 25%, with potential for expansion to over 30% through a more disciplined approach [6] - The company holds $1.15 billion in cash and short-term investments against $1.39 billion in debt, suggesting room for leveraging to fund growth initiatives and share buybacks [6] Market Dynamics - Qiagen's dual-listing and geographical revenue distribution show that 52% of its FY24 sales are from North America, 32% from Europe, the Middle East, and Africa, and 16% from Asia [4] - The company has previously engaged in discussions for potential transactions, including a failed offer from Thermo Fisher Scientific at 43 euros per share, indicating its attractiveness as an acquisition target [8] - Fivespan's investment philosophy includes evaluating strategic transactions, and while it does not prioritize sales, it remains open to advocating for shareholder value in the event of acquisition offers [8]